aMT
aMT-ominaisuudet
Synonyymi: alfa-metyylitryptamiini
CAS-numero: 299-26-3
Kaava: C11H14N2
Moolimassa: 174,247 g mol−1
Puhtaus: >98%
€34.95 – €499.95Hintaluokka: €34.95 - €499.95
* Tämän sivun tiedot ovat yhteenveto, eikä niiden ole tarkoitus kattaa kaikkia saatavilla olevia tietoja tästä lääkkeestä. Ne eivät kata kaikkia mahdollisia käyttötarkoituksia, ohjeita, varotoimia, lääkkeiden yhteisvaikutuksia tai haittavaikutuksia, eivätkä ne korvaa terveydenhuollon ammattilaisen asiantuntemusta ja harkintaa.
AMT (Alpha-Methyltryptamine) – Scientific Product Description
General Information
Substance Name: Alfa-metyylitryptamiini (AMT)
Chemical Class: Tryptamine derivative
Status: Research chemical
Dosage: Varies (10-50mg for research purposes)
Form: Powder or pellets (depending on availability)
Farmakologiset ominaisuudet
AMT is a monoamine alkaloid with a unique mechanism of action that both:
Serotonergic (5-HT₂A agonism)
Dopaminergic (dopamine reuptake inhibition)
Exhibits noradrenergic effects
Potential Research Areas
1. Neuropsychological Examination
Influence on perceptual processing
Modulation of cognitive flexibility
Effects on creative thinking
2. Behavioral Science Studies
Social interaction patterns
Emotional processing mechanisms
Motivation and reward systems
3. Theoretical Applications
Possible antidepressant effects (preclinical study)
Impact on sleep architecture
Neuroplastic changes
Dosage & Protocol
Research dose range:
Pieni annos: 10–20 mg
Keskimääräinen annos: 20–35 mg
Suuri annos: 35–50 mg
Time lapse:
Onset of effects: 45-90 minutes
Peak performance: 3-5 hours
Total duration: 8-12 hours
Safety aspects
Sivuvaikutukset
Increased body temperature
Tachycardia
Mydriaasi
Possible gastrointestinal discomfort
Contraindications
Combination with MAO inhibitors
Cardiovascular diseases
Psychiatric history
Laboratory analysis
Puhtaus: ≥97% (HPLC)
Stability: Store in a cool, dry place (<25°C)
Impurities: <0.5% (GC-MS analysis)
Oikeudellinen asema
Netherlands: Opium Act Schedule I
Belgium: Prohibited substance
EU: Under EU NPS legislation
Research protocols
Start low: 10mg initial test dose
Pharmaceutical monitoring: Blood pressure and temperature measurement
Intervals: Minimum 7 days between experiments
Important Warnings
❌ Ei ihmisravinnoksi
❌ Do not combine with other psychoactives
❌ Avoid prolonged or frequent use
This product is intended solely for in vitro research ja scientific study under controlled laboratory conditions.
1cP-LSD 150 MCG taidepaperia O-DSMT 50 mg -pelletit 1V-LSD 150 MCG -näytteenotot 6-CL-ADBA
Usein kysytyt kysymykset
Placing an order is simple:
- Browse our product catalog.
- Add desired items to your cart.
- Proceed to checkout.
- Enter your billing and shipping information.
- Complete payment using an available payment method.
- Receive an order confirmation email once your order has been successfully submitted.
Most orders are processed within 1–3 business days after payment confirmation. Processing times may vary depending on product availability, order volume, and holidays.
Once your order has been shipped, tracking information will be provided whenever available.
We serve customers in multiple countries and regions where permitted by applicable laws and regulations.
Customers are responsible for ensuring that any products ordered comply with the laws and regulations of their jurisdiction before placing an order.
Please review our Shipping Policy or contact customer support if you have questions regarding shipping availability.
If tracking is available for your shipment, you will receive a shipping confirmation email containing your tracking number and carrier information.
You can use this information to monitor the status of your shipment directly through the carrier's website.
Shipping delays can occasionally occur due to customs processing, weather conditions, carrier issues, or other unforeseen circumstances.
If your order has not arrived within the expected delivery timeframe, please contact our support team with your order number, and we will assist in investigating the shipment status.
